Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

URGNURGN
Showing 8 of 11 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in UROGEN PHARMA LTD

Yes. AQR Capital Management holds 149,228 shares of URGN (Urogen Pharma), worth $5.5M, as of its Q2 2026 13F filing. It increased the position by 5,168 shares (+3.6%) from Q1 2026. AQR Capital Management has held URGN since Q4 2023, across 11 quarterly 13F filings.

Current Value

$5.5M

Current Shares

149,228

Total Value Change

+$4M

Total Shares Change

+31,289

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
149,228
+3.6%
$5.5M0.0%$36.80
28
2026-Q1
Decreased
144,060
-6.1%
$2.6M0.0%$17.98
0
2025-Q4
Decreased
153,413
-24.9%
$3.6M0.0%$23.42
0
2025-Q3
Decreased
204,191
-11.8%
$4.1M0.0%$19.95
0
2025-Q2
Increased
231,574
+103.0%
$3.2M0.0%$13.70
43
2025-Q1
Increased
114,066
+347.5%
$1.3M0.0%$11.06
41
2024-Q4
Decreased
25,489
-78.4%
$271,4580.0%$10.65
0
2024-Q3
Increased
117,939
+289.4%
$1.5M0.0%$12.70
41

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used